2nd How to Diagnose and Treat
Acute Leukaemias
Chairs: Hervé Dombret, Arnold Ganser, Jorge Sierra, Wendy Stock

2nd How to Diagnose and Treat
Acute Leukaemias
Information
ABOUT THE CONFERENCE:
European School of Haematology (ESH) How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management on the basis of presentation, analysis and discussion of real clinical cases. One major objective is to promote interaction between the speakers and participants.
Novel and still evolving insights into the biology and diagnosis of acute leukaemias, including acute myeloid leukaemias (AMLs) and acute lymphoblastic leukaemias (ALL), is offering new therapeutic options with recent drug approvals to treat newly-diagnosed as well as relapsed/refractory disease.
The programme of this “2nd How to Diagnose and Treat: Acute Leukaemia” meeting will deal with integration of genomic analysis and cutting-edge technics in routine diagnosis, gene mutation-based therapies and new standard treatment algorithms, allogeneic haematopoietic stem cell (HSCT) transplantation and innovative immunotherapies, as well as diagnosis and management of rare acute leukaemia subtypes.
SCIENTIFIC TOPICS:
• Rare subsets of acute leukaemia
• Tracking leukaemic stem cells (LSCs)
• Routing diagnosis gene expression and mutational profiling
• Addition of a 3rd agent to frontline 7+3
• Allogeneic hematopoietic stem cell transplantation (HSCT)
• Immunotherapy for acute leukaemia
Programme
Read the final programme!




